Industry News

Pharmaceutical Industry News

With reports leaking out…

September 21st, 2026|Fierce Pharma|

With reports leaking out of investor discontent, CEO Mike Doustdar opened Novo's Capital Markets Day by acknowledging that the company’s leadership “have to convince” the audience that “there is a bright future for Novo.”

Bayer has decided to offload its…

September 21st, 2026|Fierce Pharma|

Bayer has decided to offload its aging cancer drug Stivarga to German compatriot Grünenthal as a potential new competitor from Exelixis nears an FDA decision.

Journalist-turned-menopause…

September 18th, 2026|Fierce Pharma|

Journalist-turned-menopause advocate Tamsen Fadal is using her storytelling skills to bring overlooked menopause conversations into the mainstream.

With longer progression-free…

September 18th, 2026|Fierce Pharma|

With longer progression-free survival, Jake Van Naarden, president of Lilly Oncology, told Fierce he expects most patients to choose the combination over oral SERD monotherapy.

With many of the healthcare…

September 18th, 2026|Fierce Pharma|

With many of the healthcare industry’s top marketing minds converging in the City of Brotherly Love this past week, the galvanizing power of humor, authenticity and a little outside-of-the-box thinking in an ever-changing consumer landscape

Most drug licensing deals with…

September 18th, 2026|Fierce Pharma|

Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports. Akeso and Summit's ivonescimab, B7-H3 ADCs and a surprise negative overall survival trend from Enhertu

Ultragenyx scored a belated…

September 17th, 2026|Fierce Pharma|

Ultragenyx scored a belated regulatory win with FDA approval for a first-in-disease gene therapy, giving the company a boost after a previous regulatory rejection and a recent late-stage setback.

Following the news that longtime…

September 17th, 2026|Fierce Pharma|

Following the news that longtime helmsman Paul Chaplin would be hanging up his hat at Bavarian Nordic earlier this year, the Danish vaccine maker has found a CEO replacement whose CV spans leadership roles across

Roche’s T-cell engager portfolio…

September 17th, 2026|Fierce Pharma|

Roche’s T-cell engager portfolio has notched another milestone, as a phase 3 trial of the company’s Lunsumio met its primary endpoint in earlier-line follicular lymphoma.

Eli Lilly is marking World…

September 17th, 2026|Fierce Pharma|

Eli Lilly is marking World Alzheimer’s Day with a partnership to distribute 13,500 boxes of brain-healthy fresh produce and educational materials to underserved senior populations across the U.S.

Sun Pharma is teaming up with…

September 17th, 2026|Fierce Pharma|

Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of regrowing lost hair.

The comedian sat down with Fierce…

September 17th, 2026|Fierce Pharma|

The comedian sat down with Fierce to discuss his health advocacy journey as a type 2 diabetic and his work using comedy and humor to bring light to sight-related diabetes complications in Genentech's "All Eyes

Former Publicis Health Media CEO…

September 17th, 2026|Fierce Pharma|

Former Publicis Health Media CEO Andrea Palmer has revealed her next post. The executive has taken the CEO position at Assembled Intelligence, the agency that Minds + Assembly launched last year to integrate its flurry